Study of Acupuncture on Postoperative Delirium in Patients With Diabetes Mellitus

Sponsor
Lingling Ding (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05535985
Collaborator
(none)
215
3
24

Study Details

Study Description

Brief Summary

  1. To evaluate the effectiveness and safety of acupuncture on POD in diabetic patients undergoing surgery, to provide effective prevention and treatment measures of integrated traditional Chinese and western medicine for reducing the incidence of postoperative delirium in high-risk groups, and to provide clinical basis for further promotion of integrated traditional Chinese and western medicine anesthesia in the future.

  2. To investigate the relationship between POD and rSO2 in diabetic patients undergoing surgery. To clarify the predictive value of intraoperative rSO2 monitoring on postoperative cognitive function in patients with diabetes, and to explore the effect of acupuncture on cerebral blood flow perfusion in patients with diabetes.

Condition or Disease Intervention/Treatment Phase
  • Device: acupuncture
  • Device: placebo acupuncture
N/A

Detailed Description

Postoperative delirium (POD) increases the risk of postoperative dementia and mortality. Cognitive decline is common in patients with diabetes mellitus. As an independent risk factor for POD, diabetes significantly increases postoperative dementia and mortality. Our team found that acupuncture can reduce the incidence of POD in elderly patients, increase regional cerebral oxygen saturation (rSO2), and increase cerebral blood flow perfusion in diabetic patients. In this study, a prospective randomized controlled study with placebo acupuncture will be conducted. Diabetic patients undergoing elective surgery will be divided into acupuncture group, placebo acupuncture group and control group. Acupuncture will be used as the intervention method, and the incidence of POD will be the main therapeutic effect evaluation index to explore the efficacy of acupuncture in the prevention and treatment of POD in diabetic patients undergoing surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
215 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
A Prospective Randomized Controlled Study of Acupuncture on Postoperative Delirium in Patients With Diabetes Mellitus
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: acupuncture group

In the acupuncture group, acupoints of Baihui, Shenting, Sishencong will be selected for acupuncture stimulation be anesthesia. The needle will be kept for 30 minutes, during which the needle will be performed once every 10 minutes for 10 seconds each time, 4 times in total. The therapist will give the subject verbal cues before and during the needle manipulation.

Device: acupuncture
treatment of pain or disease by inserting the tips of needles at specific points on the skin

Placebo Comparator: placebo acupuncture group

The patients will be treated with consolation needle. Choose treatment of points that near but without going through the acupoints(upper arm deltoid muscle). Use the Park needle (blunt needle, tip obtuse, when acupuncture the feeling is similar to acupuncture needles into the skin, but it retracts instead of piercing the skin) to conduct acupuncture treatment. The retention time and number of needles will be the same as those in the acupuncture group. The therapist will give the subjects verbal cues before and during the acupuncture manipulation, which further reduces the subjects' doubts about the authenticity of acupuncture in the this group. To ensure the implementation of the blinding method, all patients will be treated independently and avoid contacting with each other.

Device: placebo acupuncture
placebo acupuncture

No Intervention: control group

The patients will undergoing routine anesthesia without acupuncture treatment.

Outcome Measures

Primary Outcome Measures

  1. Incidence of postoperative delirium [at 8 a.m. the day after surgery]

    assess the incidence of postoperative delirium using the 3-minute diagnostic confusion assessment method (3D-CAM)

  2. Incidence of postoperative delirium [at 16 p.m. the day after surgery]

    assess the incidence of postoperative delirium using 3D-CAM

  3. Incidence of postoperative delirium [at 8 a.m. the second day after surgery]

    assess the incidence of postoperative delirium using 3D-CAM

  4. Incidence of postoperative delirium [at 16 p.m. the second day after surgery]

    assess the incidence of postoperative delirium using 3D-CAM

  5. Incidence of postoperative delirium [at 8 a.m. the third day after surgery]

    assess the incidence of postoperative delirium using 3D-CAM

  6. Incidence of postoperative delirium [at 16 p.m. the third day after surgery]

    assess the incidence of postoperative delirium using 3D-CAM

Secondary Outcome Measures

  1. Regional Saturation of Oxygenation (rSO2) [baseline]

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes. rSO2 values of each time point, maximum and minimum values during surgery.

  2. Regional Saturation of Oxygenation (rSO2) [the time when tracheal intubation finished]

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes. rSO2 values of each time point, maximum and minimum values during surgery.

  3. Regional Saturation of Oxygenation (rSO2) [the time when the surgery begins]

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes. rSO2 values of each time point, maximum and minimum values during surgery.

  4. Regional Saturation of Oxygenation (rSO2) [1 hour after the beginning of the surgery]

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes. rSO2 values of each time point, maximum and minimum values during surgery.

  5. Regional Saturation of Oxygenation (rSO2) [the time when the surgery ends]

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes. rSO2 values of each time point, maximum and minimum values during surgery.

  6. Regional Saturation of Oxygenation (rSO2) [Intraoperative]

    The brain oxygen saturation monitoring electrode was attached to the forehead, and the baseline level (T0) was recorded after the reading was stable under the condition of air inhalation. rSO2 readings were recorded after induction (T1), at the beginning of surgery (T2), one hour after the beginning of surgery (T3), at the end of surgery (T4), and after extubation (T5). The maximum and minimum values of rSO2 readings during surgery were recorded, and the area under the rSO2 curve was recorded when the rSO2 reading decreased by 13% from baseline for more than 5 minutes. rSO2 values of each time point, maximum and minimum values during surgery.

  7. Visual Analogue Score (VAS) [at 8 a.m. and 16 p.m. daily for 3 days after surgery]

    Record VAS. VAS is a psychometric response score. Draw a 10 cm horizontal line on the paper. The end of the line is 0, indicating no pain; the other end is 10, indicating severe pain. The middle part shows different levels of pain.

  8. Blood glucose levels [Entering the operating room, the time when the surgery ends]

    record blood glucose levels

  9. Expression of reactive oxygen species (ROS), superoxide dismutase (SOD), S100β in serum [Entering the operating room, the time when the surgery ends]

    The inflammation level will be assessed.

  10. Expression of peroxisome proliferators-activated receptor-γcoactivator-1α (PGC-1α) [Entering the operating room, the time when the surgery ends]

    assess the expression of PGC-1α

Other Outcome Measures

  1. Height [The 1 day before surgery]

    Record the height (in meters) of the patient

  2. Weight [The 1 day before surgery]

    Record the weight (in kilograms) of the patient

  3. Mini-mental state examination (MMSE) score [The 1 day before surgery]

    Scores are measured by the MMSE, with a maximum score of 30, a score between 27 and 30 is considered normal cognitive function, and a score less than 27 is considered cognitive dysfunction.

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients undergoing general anesthesia in our hospital

  • Expected duration of operation >2h

  • Ages 18-60

  • With type 2 diabetes

  • American Society of Anesthesiologists (ASA) grade 2-3 , no severe respiratory, circulation, liver, kidney, coagulation function abnormalities;

  • Expected postoperative hospital stay >3 days

  • No history of cerebrovascular accident in the past six months

  • The informed consent signed

Exclusion Criteria:
  • Unable or unwilling to cooperate with cognitive function scale tests

  • MMSE score <24

  • Refuse acupuncture treatment or have a history of needle sickness

  • With skin damage at the acupuncture sites

  • Coagulation dysfunction

  • Participated in other clinical studies

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Lingling Ding

Investigators

  • Principal Investigator: Lingling Ding, Doctor, Beijing Hospital of Traditional Chinese Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Lingling Ding, Professor, Beijing Hospital of Traditional Chinese Medicine
ClinicalTrials.gov Identifier:
NCT05535985
Other Study ID Numbers:
  • SHOUFA 2022-2-2232
First Posted:
Sep 10, 2022
Last Update Posted:
Sep 14, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Lingling Ding, Professor, Beijing Hospital of Traditional Chinese Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 14, 2022